A synthetic peptide of human apoprotein E with antibacterial activity

M Azuma1, T Kojimab, I Yokoyama

  • 1Department of Ecological Engineering, Toyohashi University of Technology, Hibarigaoka 1-1, Tenpaku-cho, Toyohashi-shi, Aichi-ken, Japan.

Peptides
|May 4, 2000
PubMed

Insights

Researchers discovered a novel antibacterial peptide derived from apoprotein E. This peptide exhibits potent antibiotic activity, similar to established antibiotics like Gentamicin.

Area of Science:

  • Biochemistry
  • Microbiology
  • Peptide Science

Background:

  • Mammalian antibacterial peptides are crucial for innate immunity.
  • Many known antibacterial peptides share an amphipathic cationic alpha-helix structure.
  • This structural motif suggests potential antibiotic activity in other peptides.

Purpose of the Study:

  • To investigate the potential antibiotic activity of a specific peptide fragment from apoprotein E.
  • To characterize the structural and functional properties of apoprotein E 133-162.
  • To compare its efficacy against known antibiotics.

Main Methods:

  • Synthesized a 30-mer peptide corresponding to apoprotein E 133-162.
  • Assessed antibiotic activity against standard bacterial strains.
  • Calculated physicochemical properties: cationicity, hydrophobicity, and hydrophobic moment.
  • Utilized helical wheel diagrams for structural analysis.

Main Results:

  • Apoprotein E 133-162 demonstrated significant antibiotic activity.
  • Its efficacy was comparable to Gentamicin and CAP18 (neutrophil-derived antibiotic peptide).
  • Structural analysis revealed similarities to CAP18, including amphipathic cationic alpha-helix features.

Conclusions:

  • Apoprotein E 133-162 represents a promising endogenous mammalian antibacterial peptide.
  • Its structural characteristics correlate with its observed antibiotic function.
  • This finding expands the repertoire of known antimicrobial peptides and their sources.

Related Concept Videos

Peptidoglycan Synthesis01:28

Peptidoglycan Synthesis

Structure of PeptidoglycanPeptidoglycan is a vital structural component of the bacterial cell wall, providing mechanical strength and shape to the cell. It consists of repeating units of two sugars—N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM)—linked by β-1,4 glycosidic bonds. These sugar chains are cross-linked by short peptide chains, forming a mesh-like polymer that surrounds the bacterial plasma membrane.Cytoplasmic Phase – Precursor SynthesisPeptidoglycan biosynthesis begins in...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...